Angiosarcomas: histology, immunohistochemistry and molecular insights with implications for differential diagnosis

被引:7
作者
Machado, Isidro [1 ,2 ]
Giner, Francisco [3 ]
Lavernia, Javier [4 ]
Cruz, Julia [1 ]
Traves, Victor [1 ]
Requena, Celia [5 ]
Llombart, Beatriz [5 ]
Antonio Lopez-Guerrero, Jose [6 ,7 ,8 ]
Llombart-Bosch, Antonio [9 ]
机构
[1] Inst Valenciano Oncol, Pathol Dept, Valencia, Spain
[2] Hosp Quinton, Pathol Dept, Valencia, Spain
[3] Univ Hosp La Fe, Pathol Dept, Valencia, Spain
[4] Inst Valenciano Oncol, Dept Oncol, Valencia, Spain
[5] Inst Valenciano Oncol, Dermatol Dept, Valencia, Spain
[6] Inst Valenciano Oncol, Lab Mol Biol, Valencia, Spain
[7] Principe Felipe Res Ctr CIPF, IVO CIPF Joint Res Unit Canc, Valencia, Spain
[8] Catholic Univ Valencia San Vicente Martir, Sch Med, Dept Pathol, Valencia, Spain
[9] Univ Valencia, Pathol Dept, Valencia, Spain
关键词
Angiosarcomas; Immunohistochemistry; Molecular biology; Differential diagnosis; ATYPICAL VASCULAR-LESIONS; POSTRADIATION CUTANEOUS ANGIOSARCOMA; ANTI-MYC IMMUNOHISTOCHEMISTRY; IN-SITU HYBRIDIZATION; SOFT-TISSUE; EPITHELIOID ANGIOSARCOMA; PSEUDOMYOGENIC HEMANGIOENDOTHELIOMA; CLINICOPATHOLOGICAL ANALYSIS; PROGNOSTIC-FACTORS; PD-L1; EXPRESSION;
D O I
10.14670/HH-18-246
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Angiosarcomas (AS) represent a heterogenous group of tumors with variable clinical presentation. AS share an important morphologic and immunohistochemical overlap with other sarcomas, hence the differential diagnosis is challenging, especially in poorly-differentiated tumors. Although molecular studies provide significant clues, especially in the differential diagnosis with other vascular neoplasms, a thorough hematoxylin and eosin analysis remains an essential tool in AS diagnosis. In this review, we discuss pathological and molecular insights with emphasis on implications for differential diagnosis in cutaneous, breast, soft tissue and visceral AS.
引用
收藏
页码:3 / 18
页数:16
相关论文
共 114 条
  • [1] Primary and secondary breast angiosarcoma: single center report and a meta-analysis
    Abdou, Yara
    Elkhanany, Ahmed
    Attwood, Kristopher
    Ji, Wenyan
    Takabe, Kazuaki
    Opyrchal, Mateusz
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2019, 178 (03) : 523 - 533
  • [2] Treatment and outcome of 82 patients with angiosarcoma
    Abraham, John A.
    Hornicek, Francis J.
    Kaufman, Adam M.
    Harmon, David C.
    Springfield, Dempsey S.
    Raskin, Kevin A.
    Mankin, Henry J.
    Kirsch, David G.
    Rosenberg, Andrew E.
    Nielsen, G. Petur
    Desphpande, Vikram
    Suit, Herman D.
    DeLancy, Thomas F.
    Yoon, Sam S.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (06) : 1953 - 1967
  • [3] Angiosarcoma arising in association with vascular Dacron grafts and orthopedic joint prostheses: clinicopathologic, immunohistochemical, and molecular study
    Agaimy, Abbas
    Ben-Izhak, Ofer
    Lorey, Thomas
    Scharpf, Marcus
    Rubin, Brian P.
    [J]. ANNALS OF DIAGNOSTIC PATHOLOGY, 2016, 21 : 21 - 28
  • [4] CD30 Expression in Malignant Vascular Tumors and Its Diagnostic and Clinical Implications: A Study of 146 Cases
    Alimchandani, Meghna
    Wang, Zeng-Feng
    Miettinen, Markku
    [J]. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2014, 22 (05) : 358 - 362
  • [5] Malignant vascular tumors-an update
    Antonescu, Cristina
    [J]. MODERN PATHOLOGY, 2014, 27 : S30 - S38
  • [6] KDR Activating Mutations in Human Angiosarcomas Are Sensitive to Specific Kinase Inhibitors
    Antonescu, Cristina R.
    Yoshida, Akihiko
    Guo, Tianhuo
    Chang, Ning-En
    Zhang, Lei
    Agaram, Narasimhan P.
    Qin, Li-Xuan
    Brennan, Murray F.
    Singer, Samuel
    Maki, Robert G.
    [J]. CANCER RESEARCH, 2009, 69 (18) : 7175 - 7179
  • [7] Association Between Programmed Death-Ligand 1 Expression and the Vascular Endothelial Growth Factor Pathway in Angiosarcoma
    Bagaria, Sanjay P.
    Gatalica, Zoran
    Maney, Todd
    Serie, Daniel
    Parasramka, Mansi
    Attia, Steven
    Krishna, Murli
    Joseph, Richard W.
    [J]. FRONTIERS IN ONCOLOGY, 2018, 8
  • [8] Vascular lesions of the breast
    Baker, Gabrielle M.
    Schnitt, Stuart J.
    [J]. SEMINARS IN DIAGNOSTIC PATHOLOGY, 2017, 34 (05) : 410 - 419
  • [9] Primary mammary angiosarcomas harbor frequent mutations in KDR and PIK3CA and show evidence of distinct pathogenesis
    Beca, Francisco
    Krings, Gregor
    Chen, Yunn-Yi
    Hosfield, Elizabeth M.
    Vohra, Poonam
    Sibley, Richard K.
    Troxell, Megan L.
    West, Robert B.
    Allison, Kimberly H.
    Bean, Gregory R.
    [J]. MODERN PATHOLOGY, 2020, 33 (08) : 1518 - 1526
  • [10] Recurrent PTPRB and PLCG1 mutations in angiosarcoma
    Behjati, Sam
    Tarpey, Patrick S.
    Sheldon, Helen
    Martincorena, Inigo
    Van Loo, Peter
    Gundem, Gunes
    Wedge, David C.
    Ramakrishna, Manasa
    Cooke, Susanna L.
    Pillay, Nischalan
    Vollan, Hans Kristian M.
    Papaemmanuil, Elli
    Koss, Hans
    Bunney, Tom D.
    Hardy, Claire
    Joseph, Olivia R.
    Martin, Sancha
    Mudie, Laura
    Butler, Adam
    Teague, Jon W.
    Patil, Meena
    Steers, Graham
    Cao, Yu
    Gumbs, Curtis
    Ingram, Davis
    Lazar, Alexander J.
    Little, Latasha
    Mahadeshwar, Harshad
    Protopopov, Alexei
    Al Sannaa, Ghadah A.
    Seth, Sahil
    Song, Xingzhi
    Tang, Jiabin
    Zhang, Jianhua
    Ravi, Vinod
    Torres, Keila E.
    Khatri, Bhavisha
    Halai, Dina
    Roxanis, Ioannis
    Baumhoer, Daniel
    Tirabosco, Roberto
    Amary, M. Fernanda
    Boshoff, Chris
    McDermott, Ultan
    Katan, Matilda
    Stratton, Michael R.
    Futreal, P. Andrew
    Flanagan, Adrienne M.
    Harris, Adrian
    Campbell, Peter J.
    [J]. NATURE GENETICS, 2014, 46 (04) : 376 - +